Recent China medical-device activity, turned into evidence-backed sales leads.
For U.S. Agents, EU/UK representatives, and MedTech regulatory consultancies. Receive public-source company opportunities with business contact channels, registry matching, confidence grades, and cautious "why now" notes — 30 or 60 companies per pack.
One pack, one quarter of outreach
- Chinese-domiciled registrants with recent NMPA activity
- Public business contact channels and official websites
- Cross-market registry matching with confidence grades
- 12 companies with confirmed FDA establishment registrations
- Delivery within 48 hours after verified full payment
Who this is for
Firms whose revenue depends on finding the next foreign medical-device manufacturer that needs representation or compliance help:
FDA U.S. Agent providers
Chinese manufacturers filing new NMPA device records are your fastest-growing prospect pool. Each record shows the registrant, product category, and when the activity happened.
EU/UK authorised representatives and consultancies
EUDAMED Actor registration became mandatory in May 2026. Manufacturers with fresh domestic activity and export-ready signals are timely outreach targets for EU AR, UKRP, ISO 13485, and CE services.
What each record includes
| Field group | What you get |
|---|---|
| Identity | Company name (Chinese and English when published), unified social credit code, province decoded from the GB 32100-2015 code. |
| Contact | Published business email and official website from public sources, with retrieval dates. |
| Activity | NMPA activity date, count of new device records, representative products, registration references, and product category. |
| Evidence | Cross-market registry matching (e.g., FDA registration-listing data), confidence grade A or B, source links, and a cautious "why now" note. |
| Guidance | A suggested outreach angle per company — no outreach performed on your behalf. |
Evidence and confidence method
Source NMPA UDI daily releases (udid.nmpa.gov.cn), checksum-verified before parsing.
Honest limits Recent NMPA activity is a commercial timing signal, not compliance proof. openFDA matching is deliberately conservative: ambiguous or failed queries become "review" or "unknown", never a silent assumption.
Every paid lead passes evidence gates: an official regulatory source, an independent corporate source, a published business contact, working source links, a retrieval date, confidence grade A or B, a grounded "why now" statement, and an independent second-pass validation.
Scoring model
1.0.0, weighted across recency, volume and commercial relevance, export readiness, target-market opportunity, and contactability. The evidence threshold is never silently lowered.
If fewer than 30 companies can pass the evidence gate, the purchase is handled through an agreed replacement, agreed reduced scope, agreed extension, or refund review — never by lowering quality.
Offers
30-company direct pack
- XLSX lead pack
- Executive PDF brief
- Source links and retrieval dates for every record
- Delivery within 48 hours after verified full payment
- Non-exclusive, internal use by one purchasing company
Every company must pass the full evidence gate (official source, independent corporate source, working links, confidence grade A or B, grounded "why now", and second-pass validation). If fewer than 30 pass, we agree a reduced scope at a proportional price — never a lowered quality bar.
Pay USD 369 with PayPal Order via emailPro 60-company pack
- All 60 evidence-passed companies (12 with confirmed FDA establishment registrations)
- XLSX lead pack and executive PDF brief
- Source links and retrieval dates for every record
- Delivery within 48 hours after verified full payment
- Non-exclusive, internal use by one purchasing company
Same evidence gates as the 30-company pack — a larger prospect pool at a lower per-lead price (USD 9.98 per company).
Pay USD 599 with PayPal Order via emailBefore you order
Download the public sample to inspect the format and source fields. If it fits your sales motion, use the PayPal button on the pack you want, or email us and we will confirm scope and delivery.
Payment is collected through a verified PayPal account; the pack is delivered within 48 hours after the payment clears. If you pay with the button, please include your email in the PayPal note so we can deliver to you.
Download sample (XLSX)FAQ
Who is this for?
FDA U.S. Agent providers, EU/UK authorised representatives, and medical-device regulatory consultancies that sell representation, registration, certification, or market-entry services to foreign manufacturers.
What does one record include?
Company identity (Chinese and English when published), province, unified social credit code, official website, published business email, NMPA activity date, new device records, representative products, registration references, product category, cross-market match evidence, confidence grade, "why now", suggested outreach angle, source links, and retrieval date.
Is this legal or regulatory advice?
No. This is a sales-intelligence product built from public sources. It is not a legal opinion, regulatory verification, compliance determination, or official database, and it makes no claim about any company's FDA or EUDAMED registration status.
Are the leads exclusive?
No. Each pack is licensed non-exclusively for internal use by one purchasing company. Resale and republication are prohibited. We may sell packs covering the same companies to other buyers.
What happens if 30 records cannot pass the evidence gate?
We never lower the evidence threshold. You would receive an agreed replacement, an agreed reduced scope at a proportional price, an agreed extension, or a refund review — whichever we agree on first.
How is payment handled?
Through a verified business PayPal account after a written order confirmation. The pack is delivered within 48 hours after verified full payment. No card data is collected on this site.
Request the 3-company sample
Tell us how you sell into China-origin medical-device manufacturers. We will send the real-data sample and answer questions.